GENOMAS, INC.

Company Information

Company Name
GENOMAS, INC.
Address
67 JEFFERSON ST
HARTFORD, CT, 06106
Phone
n/a
URL
n/a
DUNS
147969526
Number of Employees
5
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$650,338.00
3
SBIR Phase II
$4,939,763.00
4
Chart code to be here

Award List

  1. Physiogenomic Arrays for Clinical Neuropsychiatry

    Amount: $400,000.00

    DESCRIPTION (provided by applicant): Neuropsychiatric and neurodegenerative disorders such as schizophrenia, Alzheimer's disease, and depression are genetically complex diseases with multiple contribu ...

    SBIR Phase I 2005 Department of Health and Human Services
  2. Gene Markers: Antipsychotic-Induced Metabolic Syndrome

    Amount: $107,000.00

    DESCRIPTION (PROVIDED BY APPLICANT): This Phase I SBIR Program will develop genetic diagnostic products to improve the safety of atypical antipsychotics (e.g. olanzapine) for treating psychiatric diso ...

    SBIR Phase I 2005 Department of Health and Human Services
  3. DNA Diagnostic System for Statin Safety and Efficacy

    Amount: $143,338.00

    DESCRIPTION (provided by applicant): Statins are the most prescribed drugs in the world. Their efficacy in primary and secondary prevention of cardiovascular disease as well as beneficial pleiotrophic ...

    SBIR Phase I 2008 Department of Health and Human Services
  4. DNA Diagnostic System for Statin Safety and Efficacy

    Amount: $1,008,599.00

    DESCRIPTION (provided by applicant): Statins are the most prescribed drugs in the world. Their efficacy in primary and secondary prevention of cardiovascular disease as well as beneficial pleiotrophic ...

    SBIR Phase II 2008 Department of Health and Human Services
  5. DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics

    Amount: $1,331,188.00

    DESCRIPTION (provided by applicant): Atypical antipsychotic drugs (AAPs) are indicated in the treatment for schizophrenia, bipolar disorder, psychotic depression and other psychiatric disorders. Their ...

    SBIR Phase II 2007 Department of Health and Human Services
  6. MRI DNA Biomarkers for Neuropsychiatric Disease

    Amount: $1,349,949.00

    DESCRIPTION (provided by applicant): Schizophrenia (SZ) is a severely debilitating mental illnesses. It is highly heritable, with concordance rates of 50-80% in monozygotic twins and substantial famil ...

    SBIR Phase II 2009 Department of Health and Human Services
  7. System for DNA-Guided Optimization and Personalization of Statin Therapy

    Amount: $1,250,027.00

    DESCRIPTION (provided by applicant): Currently 30 million Americans with elevated cholesterol receive statin therapy, making statins the most prescribed drug class in the U.S. Statin Induction and Neu ...

    SBIR Phase II 2011 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government